Primary mediastinal large B-cell lymphoma: A single-institution clinical study in Japan

International Journal of Hematology

Volumn 79, Issue 5, 2004, Pages 465-471

  Sekiguchi, Naohiro ^a   Nishimoto, Junko ^a   Tanimoto, Kazuki ^a   Kusumoto, Shigeru ^a   Onishi, Yasushi ^a   Watanabe, Takashi ^a   Kobayashi, Yukio ^a   Asamura, Hisao ^a   Kagami, Yoshikazu ^a   Matsuno, Yoshihiro ^a   Tobinai, Kensei ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Geographical variation; Japan; Primary mediastinal large B cell lymphoma; Prognostic factor; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISOLONE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; JAPAN; MALE; MEDIASTINUM TUMOR; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; JAPAN; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; VINCRISTINE;

EID: 3042658501     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03173     Document Type: Article

References (37)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 1994;84:1361-1392.
2. Banks PM, Warnke RA. Mediastinal (thymic) large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:175-176.
3. Lazzarino M, Orlandi E, Paulli M, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol. 1997;15: 1646-1653.
4. Cazals-Hatem D, Lepage E, Brice P, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared 916 nonmediastinal large B-cell lymphomas: a GELA ("Groupe d'Etude des lymphomas de I'Adulte") study. Am J Surg Pathol. 1996;20:877-888.
5. Besien KV, Kelta M, Bahaguna P. Primary mediastinal B-cell lymphoma: a review of pathology and management. J Clin Oncol. 2001; 19:1855-1864.
6. Falini B, Venturi S, Martelli M, et al. Mediastinal large B-cell lymphoma: clinical and immunohistologic findings in 18 patients treated with different third-generation regimens. Br J Haematol. 1995;89:780-789.
7. Zinzani PL, Martelli M, Bertini M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica. 2002;87:1258-1264.
8. Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67) gallium scan in 50 patients. Blood. 1999;94:3289-3293.
9. Bieri S, Roggero E, Zucca E, et al. Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials. Leuk Lymphoma. 1999;35:139-146.
10. Haioun C, Gaulard P, Roudot-Thoraval F, et al. Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol. 1989;12:425-429.
11. Jacobson JO, Aisenberg AC, Lamarre L, et al. Mediastinal large cell lymphoma, an uncommon subset of adult lymphoma curable with combined modality therapy. Cancer. 1988;62:1893-1898.
12. Kirn D, Mauch P, Shaffer K, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993;11:1336-1343.
13. Abou-Elella AA, Weisenburger DD, Vose JM, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol. 1999;17:784-790.
14. Yonetani N, Kurata M, Nishikori M, et al. Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease. Int J Hematol. 2001;74:178-185.
15. Nakagawa A, Nakamura S, Koshikawa T, et al. Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese. Acta Pathol Jpn. 1993;43:44-54.
16. Itami J, Hara R, Komiyama T, et al. Role of radiation therapy in the management of primary mediastinal large B-cell lymphoma (PMLBL). Rad Med. 2002;20:311-318.
17. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851-862.
18. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871-3879.
19. Lossos IS, Levy R. Diffuse large B-cell lymphoma: insights gained from gene expression profiling. Int J Hematol. 2003;77:321-329.
20. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol. 1983;14:745-772.
21. International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
22. Green FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002:393-403.
23. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971; 31:1860-1861.
24. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
25. Lister TA, Crowther D, Sutcliffe SB, et al. Report of committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds Meeting. J Clin Oncol. 1989;7: 1630-1636.
26. Shimoyama M, Ota K, Kikuchi M, et al. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol. 1988;6: 128-141.
27. Tobinai K, Shimoyama M, Minato K, et al. Japan Clinical Oncology Group phase II trial of second-generation "LSG4 protocol" in aggressive T- and B-lymphoma: a new predictive model for T- and B-lymphoma [abstract]. Proc Am Soc Clin Oncol. 1994;13:378.
28. Kinoshita T, Hotta T, Tobinai K, et al. Randomized phase III trial investigating survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade nonHodgkin's lymphoma (NHL): Japan Clinical Oncology Group (JCOG) Study (JCOG9002) [abstract]. Proc Am Soc Clin Oncol. 2002;21:289a.
29. Lamarre L, Jacobson JO, Aisenberg AC, Harris NL. Primary large cell lymphoma of the mediastinum: a histologic and immunophenotypic study of 29 cases. Am J Surg Pathol. 1989;13: 730-739.
30. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
31. Armitage JO, Weisenburger DD. New approach to classifying nonHodgkin's lymphomas: clinical features of the major histologic subtypes: Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795.
32. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol. 1998;9:717-720.
33. Toh HC, Koh CH, Ang PT. Primary mediastinal large cell lymphoma in an aggressive and chemorefractory subtype in an Asian diffuse large cell lymphoma series. Med Pediatr Oncol. 1998;31:125.
34. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50: 696-702.
35. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med. 1985;102: 596-602.
36. Sehn LH, Antin JH, Shulman LN, et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood. 1998;91:717-723.
37. Popat U, Przepiorka D, Champlin R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts a favorable prognosis. J Clin Oncol. 1998;16:63-69.